Sự tái phát tại vùng chậu sau điều trị bức xạ nội trực tràng liều cao cho bệnh nhân ung thư trực tràng có thể mổ
Tóm tắt
Từ khóa
#bất thường tại chậu #điều trị bức xạ nội trực tràng liều cao #ung thư trực tràng có thể mổ #tái phát tại chỗ #độ sống sót tổng thểTài liệu tham khảo
•• Nagtegaal ID, Quirke P: What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 2008, 26:303–12. This article describes the importance of CRM in local recurrence and distant metastases.
Heald RJ: The ‘Holy Plane’ of rectal surgery: J R Soc Med 1988, 81:503–508.
Heald RJ, Moran BJ, Ryall RD, et al.: Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 1998, 133:894–899.
Enker WE, Thaler HT, Cranor ML, Polyak T: Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995, 181:335–346.
MacFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. Lancet 1993, 341:457–460.
Martling AL, Holm T, Rutqvist LE, et al.: Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000, 356:93–96.
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638–646.
•• Peeters KC, Marijnen CA, Nagtegaal ID, et al.: The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007, 246:693–701. This article describes the benefit of EBRT in the era of TME surgery.
Vuong T, Richard C, Niazi T, et al.: High dose rate endorectal brachytherapy for patients with curable rectal cancer. Semin Colon Rectal Surg 2010, 21:115–119. This article describes the oncologic outcome of patients treated with neoadjuvant HDREBT.
Vuong T, Devic S, Moftah B, et al.: High dose rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects. Brachytherapy 2005, 4:230–235.
Beets GL, Beets-Tan RGH, Lahaye M, et al.: Mechanisms of local recurrence after rectal cancer resection. What can we learn from the Dutch TME trial? [abstract O1.04]. Ann Oncol 2006, 17:i14.
Bosset JF, Collette L, Calais G, et al.: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114–1123.
Roels S, Duthoy W, Haustermans K, et al.: Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 2006, 65:1129–1142.
• Myerson RJ, Garofalo MC, El Naqa I, et al.: Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel coutouring atlas. Int J Radiat Oncol Biol Phys 2009, 74:824–830. This article represents the expert consensus on clinical target volume for patients with rectal cancer.
•• Nijkamp J, Kusters M, Beets-Tan RGH, et al.: Three dimensional analysis of recurrence patterns in rectal cancer: the cranial border in hypofractionated preoperative radiotherapy can be lowered. Int J Radiat Oncol Biol Phys 2010 June 21 (Epub ahead of print). This article describes the pattern of recurrence in the era of TME surgery after preoperative radiotherapy from the Dutch study.
Syk E, Torkzad MR, Blomqvist L, et al.: Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg 2006, 93:113–119.
•• Syk E, Torkzad M, Blomqvist L, et al.: Local recurrence in rectal cancer: anatomic localization and effect on radiation target. Int J Radiat Oncol Biol Phys 2008, 72:658–664. This article describes the pattern of recurrence in the era of TME surgery after preoperative radiotherapy from the Swedish group.
Steup WH, Moriya Y, Velde V: Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer 2002, 38:911–918.